Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Davidson

Showing results (91-100 of 141) with videos related to

Pageof 15
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2003
Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex depositionLena Schiffer, Jayashree Sinha, Xiaobo Wang, et al.
Arthritis and Rheumatism|June 8, 2012
Anti-tumor necrosis factor α treatment of interferon-α-induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formationRamalingam Bethunaickan, Ranjit Sahu, Zheng Liu, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
A randomized multiplex CRISPRi-Seq approach for the identification of critical combinations of genesNicole A Ellis, Kevin S Myers, Jessica Tung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 18, 2011
A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritisRamalingam Bethunaickan, Celine C Berthier, Meera Ramanujam, et al.
Elife|December 14, 2023
A randomized multiplex CRISPRi-Seq approach for the identification of critical combinations of genesNicole A Ellis, Kevin S Myers, Jessica Tung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2005
Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black x New Zealand White)F1 miceClaire Forestier, Alberto Molano, Jin Seon Im, et al.
BMC Geriatrics|October 23, 2019
A four-stage process for intervention description and guide development of a practice-based intervention: refining the Namaste Care intervention implementation specification for people with advanced dementia prior to a feasibility cluster randomised trialCatherine Walshe, Julie Kinley, Shakil Patel, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophagesAntigoni Triantafyllopoulou, Claus-Werner Franzke, Surya V Seshan, et al.
Clinical Immunology (Orlando, Fla.)|July 2, 2014
Interferon alpha on NZM2328.Lc1R27: enhancing autoimmunity and immune complex-mediated glomerulonephritis without end stage renal failureChao Dai, Hongyang Wang, Sun-Sang J Sung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2008
Activated renal macrophages are markers of disease onset and disease remission in lupus nephritisLena Schiffer, Ramalingam Bethunaickan, Meera Ramanujam, et al.
Pageof 15

Showing results (91-100 of 141) with videos related to

Sort By:
Pageof 15
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2003
Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex depositionLena Schiffer, Jayashree Sinha, Xiaobo Wang, et al.
Arthritis and Rheumatism|June 8, 2012
Anti-tumor necrosis factor α treatment of interferon-α-induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formationRamalingam Bethunaickan, Ranjit Sahu, Zheng Liu, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
A randomized multiplex CRISPRi-Seq approach for the identification of critical combinations of genesNicole A Ellis, Kevin S Myers, Jessica Tung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 18, 2011
A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritisRamalingam Bethunaickan, Celine C Berthier, Meera Ramanujam, et al.
Elife|December 14, 2023
A randomized multiplex CRISPRi-Seq approach for the identification of critical combinations of genesNicole A Ellis, Kevin S Myers, Jessica Tung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2005
Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black x New Zealand White)F1 miceClaire Forestier, Alberto Molano, Jin Seon Im, et al.
BMC Geriatrics|October 23, 2019
A four-stage process for intervention description and guide development of a practice-based intervention: refining the Namaste Care intervention implementation specification for people with advanced dementia prior to a feasibility cluster randomised trialCatherine Walshe, Julie Kinley, Shakil Patel, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophagesAntigoni Triantafyllopoulou, Claus-Werner Franzke, Surya V Seshan, et al.
Clinical Immunology (Orlando, Fla.)|July 2, 2014
Interferon alpha on NZM2328.Lc1R27: enhancing autoimmunity and immune complex-mediated glomerulonephritis without end stage renal failureChao Dai, Hongyang Wang, Sun-Sang J Sung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2008
Activated renal macrophages are markers of disease onset and disease remission in lupus nephritisLena Schiffer, Ramalingam Bethunaickan, Meera Ramanujam, et al.
Pageof 15